Anemia and iron deficiency are important and common comorbidities that often coexist in
patients with heart failure. Both conditions, together or independently, are associated with …

Anemia is a common comorbidity in patients with heart failure and is associated with worse
long-term outcomes. Although the cause of anemia in heart failure is unclear, the weight of …

Background Whether correction of anemia in patients with stage 3 or 4 chronic kidney
disease improves cardiovascular outcomes is not established. Methods We randomly …

Background: Evidence suggests that brain iron deficiency at any time in life may disrupt
metabolic processes and subsequently change cognitive and behavioral functioning …

Although treating anemia of chronic kidney disease by erythropoiesis-stimulating agents
(ESA) may improve survival, most studies have examined associations between baseline …

It is unclear whether physiologic hemoglobin targets lead to cardiac benefit in incident
hemodialysis patients without symptomatic heart disease and left ventricular dilation. In this …

The proper measures for assessing quality of life (QOL) in patients with chronic kidney
disease (CKD) remain unclear. QOL measures are subjective or objective, functional or …

Background. Partial correction of renal anaemia with erythropoietin improves quality of life
(QoL). We aimed to examine if normalization of haemoglobin with epoetin alfa in pre …

The effects of higher hemoglobin levels on mortality and hospitalization in hemodialysis
patients. Background The introduction of recombinant human erythropoietin for the treatment …

Background. Chronic kidney disease (CKD) patients are highly prone to cardiovascular
disease for a number of reasons. At the time of starting renal replacement treatment, their …